Enliven Therapeutics Inc. (ELVN)

Market is closed
Insider Trading: Purchases
Insider Price Amount Relationship Remaining Holdings Date Form 4
$1.56 65,817 Director 193,967 2022-02-22 Filing
$1.30 50,398 Director 128,150 2022-02-18 Filing
$1.17 14,595 Director 77,752 2022-02-17 Filing
$1.20 11,779 Director 63,157 2022-02-16 Filing
$1.20 19,552 Director 51,378 2022-02-15 Filing
$1.18 8,500 Director 31,826 2022-02-14 Filing
$1.23 14,573 Director 23,326 2022-02-11 Filing
$1.29 8,753 Director 8,753 2022-02-10 Filing
$6.00 1,333,333 Director 2,344,072 2021-07-16 Filing
$6.00 1,666,666 Large Shareholder, Director 4,199,068 2021-07-16 Filing
$6.00 1,666,666 Large Shareholder, Director 4,199,068 2021-07-16 Filing
$6.00 1,666,666 Large Shareholder, Director 1,666,666 2021-07-16 Filing
$6.00 1,666,666 Large Shareholder, Director 1,666,666 2021-07-16 Filing
$16.00 625,000 Large Shareholder 1,454,348 2020-03-16 Filing
$16.00 312,500 Large Shareholder 1,481,719 2020-03-16 Filing
$16.00 312,500 Large Shareholder, Director 1,557,722 2020-03-16 Filing
$16.00 937,500 Large Shareholder, Director 937,500 2020-03-12 Filing
$16.00 187,500 Large Shareholder, Director 1,432,722 2020-03-16 Filing
$16.00 475,000 Large Shareholder 4,013,995 2020-03-16 Filing
$16.00 187,500 Large Shareholder, Director 1,554,558 2020-03-16 Filing